3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Andrographis paniculata extract: new trials by email Literature Review of Andrographis paniculata extract trials Research Report on Andrographis paniculata extract
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS) 1 - Andrographis paniculata p/st extract, 2 - Excipients - Multiple Sclerosis, Relapsing-Remitting | Phase 1 / Phase 2 | Completed | Universidad Austral de Chile | 30 | 2012-01-01 | 2016-06-23 |
| Phase II Study of HMPL-004 in Patients With Ulcerative Colitis HMPL-004 low dose, Placebo, HMPL-004 high dose - Ulcerative Colitis | Phase 2 | Completed | Hutchison Medipharma Limited | 224 | 2008-02-07 | 2020-07-22 |
| Phase II Study of HMPL-004 in Subjects With Crohn's Disease HMPL-004, Placebo - Crohn's Disease | Phase 2 | Completed | Hutchison Medipharma Limited | 101 | 2006-04-01 | 2020-01-02 |
Colitis, Ulcerative (1) · Crohn Disease (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Nervous System Diseases (1)
Hutchison Medipharma Limited (2) · Universidad Austral de Chile (1)
Chile (1)
Juan L. Hancke, PhD (1) · Rongjun Liu, MD (1)